Item


Interferon/STAT1 and neuregulin signaling pathways are exploratory biomarkers of cetuximab (Erbitux®) efficacy in KRAS wild-type squamous carcinomas: A pathway-based analysis of whole human-genome microarray data from cetuximab-adapted tumor cell-line models

Spandidos Publications

Date: 2018 June 1
Document access: http://hdl.handle.net/2072/312153
Publisher: Spandidos Publications
Rights: Tots els drets reservats
Subject: Recte -- Càncer
Rectum -- Cancer
Marcadors tumorals
Tumor markers
Title: Interferon/STAT1 and neuregulin signaling pathways are exploratory biomarkers of cetuximab (Erbitux®) efficacy in KRAS wild-type squamous carcinomas: A pathway-based analysis of whole human-genome microarray data from cetuximab-adapted tumor cell-line models
Type: info:eu-repo/semantics/article
Repository: Recercat

Subjects

Authors